Skip to main content
Log in

Antiarrhythmic Prophylaxis after Acute Myocardial Infarction

Is Lidocaine Still Useful?

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Adgey AAJ, Allen JD, Geddes JS, James RGG, Webb SW, et al. Acute phase of myocardial infarction. Lancet 2: 501–504, 1971

    Article  PubMed  CAS  Google Scholar 

  • Antman EM, Berlin JA. Declining incidence of ventricular fibrillation in myocardial infarction: implications for the use of lidocaine. Circulation 84 (Suppl. II): 11–712, 1991

    Google Scholar 

  • Bromage PR, Robson JG. Concentrations of lignocaine in the blood after intravenous, intramuscular epidural and endotracheal administration. Anaesthesia 16: 461–478, 1961

    Article  PubMed  CAS  Google Scholar 

  • Cox JR, Roberts R, Ambos HD, Oliver GC, Sobel BE. Relations between enzymatically estimated myocardial infarct size and early ventricular dysrhythmia. Circulation 53 (Suppl. I): I150–I155, 1976

    PubMed  Google Scholar 

  • Cusson J, Nattel S, Matthews C, Talajic M, Lawand S. Age-dependent lidocaine disposition in patients with acute myocardial infarction. Clinical Pharmacology and Therapeutics 37: 381–385, 1985

    Article  PubMed  CAS  Google Scholar 

  • De Soyza N, Meacham D, Murphy ML, Kane JJ, Doherty JE, et al. Evaluation of warning arrhythmias before paroxysmal ventricular tachycardia during acute myocardial infarction in man. Circulation 60: 815–818, 1979

    Google Scholar 

  • Dunn HM, McComb JM, Kinney CD, Campbell NPS, Shanks RG. Prophylactic lidocaine in the early phase of suspected myocardial infarction. American Heart Journal 110: 353–362, 1985

    Article  PubMed  CAS  Google Scholar 

  • Fulton M, Julian DG, Oliver MF. Sudden death and myocardial infarction. Circulation 40 (Suppl. 4): 182–193, 1969

    Article  Google Scholar 

  • Goldman L, Batsford WP. Risk-benefit stratification as a guide to lidocaine prophylaxis of primary ventricular fibrillation in acute myocardial infarction: an analytic review. Yale Journal of Biology and Medicine 52: 455–466, 1979

    PubMed  CAS  Google Scholar 

  • Harrison DC, Berte LE. Should prophylactic antiarrhythmic drug therapy be used in acute myocardial infarction?. Journal of the American Medical Association 247: 2019–2021, 1982

    Article  PubMed  CAS  Google Scholar 

  • Hine LK, Laird N, Hewitt P, Chalmers TC. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Archives of Internal Medicine 149: 2694–2698, 1989

    Article  PubMed  CAS  Google Scholar 

  • Horwitz RI, Feinstein AR. Improved observational method for studying therapeutic efficacy. Suggestive evidence that lidocaine prophylaxis prevents death in acute myocardial infarction. Journal of the American Medical Association 246: 2455–2459, 1981

    Article  PubMed  CAS  Google Scholar 

  • Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiological Reviews 69: 1049–1169, 1989

    PubMed  CAS  Google Scholar 

  • Jewitt DE, Kishon Y, Thomas M. Lignocaine in the management of arrhythmias after acute myocardial infarction. Lancet 1: 266–270, 1968

    Article  Google Scholar 

  • Julian DG, Valentine PA, Miller GG. Disturbances of rate, rhythm and conduction in acute myocardial infarction. American Journal of Medicine 37: 915–927, 1964

    Article  PubMed  CAS  Google Scholar 

  • Kertes P, Hunt D. Prophylaxis of primary ventricular fibrillation in acute myocardial infarction: the case against lignocaine. British Heart Journal 52: 241–247, 1984

    Article  PubMed  CAS  Google Scholar 

  • Koster RW, Dunning AJ. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. New England Journal of Medicine 313: 1105–1110, 1985

    Article  PubMed  CAS  Google Scholar 

  • Lie KI, Wellens HJ, van Capelle FJ, Durrer D. Lidocaine in the prevention of primary ventricular fibrillation: a double-blind, randomized study of 212 consecutive patients. New England Journal of Medicine 291: 1324–1326, 1974

    Article  PubMed  CAS  Google Scholar 

  • Lie KI, Wellens HJJ, Downar E, Durrer D. Observations on patients with primary ventricular fibrillation complicating acute myocardial infarction. Circulation 52: 755–759, 1975

    Article  PubMed  CAS  Google Scholar 

  • Lown B, Fakhro AM, Hood WB. The coronary care unit. New perspectives and directions. Journal of the American Medical Association 199: 188–198, 1967

    Article  PubMed  CAS  Google Scholar 

  • MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. Journal of the American Medical Association 260: 1910–1916, 1988

    Article  PubMed  CAS  Google Scholar 

  • Nattel S, Gagne G, Pineau M. The pharmacokinetics of lignocaine and β-adrenoceptor antagonists in patients with acute myocardial infarction. Clinical Pharmacokinetics 13: 293–316, 1987

    Article  PubMed  CAS  Google Scholar 

  • Nattel S, Waters D. What is an antiarrhythmic drug? From clinical trials to fundamental concepts. American Journal of Cardiology 66: 96–99, 1990

    Article  PubMed  CAS  Google Scholar 

  • Noneman JW, Rogers JF. Lidocaine prophylaxis in acute myocardial infarction. Medicine 57: 501–515, 1978

    Article  PubMed  CAS  Google Scholar 

  • Pasternak RC, Braunwald E, Sobel BE. Acute myocardial infarction. In Braunwald E (Ed.) Heart disease, 4th ed., Vol. 2, pp. 1200–1291, W.B. Saunders Company, Philadelphia, 1992

    Google Scholar 

  • Pfeifer HJ, Greenblatt DJ, Koch-Weiser J. Clinical use and toxicity of intravenous lidocaine. American Heart Journal 92: 168–173, 1976

    Article  PubMed  CAS  Google Scholar 

  • Pitt A, Lipp H, Anderson ST. Lignocaine given prophylactically to patients with acute myocardial infarction. Lancet 1: 612–616, 1971

    Article  PubMed  CAS  Google Scholar 

  • Ribner HS, Isaacs ES, Frishman WH. Lidocaine prophylaxis against ventricular fibrillation in acute myocardial infarction. Progress in Cardiovascular Diseases 21: 287–313, 1979

    Article  PubMed  CAS  Google Scholar 

  • Roberts R, Husain A, Ambos HD, Oliver GC, Cox JR, et al. Relation between infarct size and ventricular arrhythmia. British Heart Journal 37: 1169–1175, 1975

    Article  PubMed  CAS  Google Scholar 

  • Volpi A, Maggioni A, Franzosi MG, Pampailona S, Mauri F, et al. In-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. New England Journal of Medicine 317: 257–261, 1987

    Article  PubMed  CAS  Google Scholar 

  • Wyse G, Kellen J, Rademaker AW. Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction. Journal of the American College of Cardiology 12: 507–513, 1988

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nattel, S., Arenal, A. Antiarrhythmic Prophylaxis after Acute Myocardial Infarction. Drugs 45, 9–14 (1993). https://doi.org/10.2165/00003495-199345010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199345010-00002

Keywords

Navigation